Stay tuned and follow the latest
developments and news in Molecular Oncology.
This year, our team attended the San Antonio Breast Cancer Symposium (SABCS) in Texas, a key event in breast cancer research. It was a great opportunity to connect with healthcare […]
Read MoreSource: Iatronet Nikolaos Tsoulos, MBA, PhD, Molecular Biochemist, CEO of GeneKor Medical SA, and Chairman of the Hellenic Society of Diagnostic Laboratories (EDEM), spoke to Iatronet about accredited diagnostic laboratories […]
Read MoreDr. George Nasioulas, Scientific Director of Genekor Medical S.A. and Molecular Biologist, PhD gave an interview on Shape.gr about liquid biopsies and how they change the prognosis of pancreatic cancer. Pancreatic […]
Read MoreGenekor’s Pathology Laboratory now offers the Claudin 18.2 (CLDN 18.2) test, used to administer Zolbetuximab in combination with chemotherapy for patients with advanced or metastatic gastric adenocarcinoma and gastroesophageal junction […]
Read MoreThe FRα test is performed for the administration of mirvetuximab soravtansine and is aimed at patients with platinum-resistant ovarian cancer who are FRα-positive and have received 1-3 lines of therapy. […]
Read MoreThe application of next-generation sequencing (NGS) technology in the genetic investigation of hereditary cancer is important for clinical surveillance, therapeutic approach, and reducing the risk of developing new malignancies. The […]
Read MoreGenekor announces the opening of our new pathology laboratory. Genekor’s experienced and qualified staff is here to provide you with the most reliable and valid results to enhance your efforts […]
Read MoreGenekor participated again this year in the European Human Genetics Conference 2024 held in Berlin, where Dr. Konstantinos Agiannitopoulos, Molecular Biologist, Ph.D and Group Leader of Genekor’s Hereditary Cancer Group, […]
Read MoreBreast cancer remains the most common type of cancer among women worldwide and remains the leading cause of death. Neuroendocrine breast cancer (NBC), a rare subtype that occurs in less […]
Read More